Thrivent Financial For Lutherans Vericel Corp Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Vericel Corp stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 412,967 shares of VCEL stock, worth $24.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

412,967

Previous 449,094 8.04%

Holding current value

$24.4 Million

Previous $20.6 Million 15.32%

% of portfolio

0.03%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$42.25 - $53.56 $1.53 Million - $1.93 Million	-36,127 Reduced 8.04%	412,967 $17.4 Million
Q2 2024 Aug 13, 2024	SELL	$41.71 - $52.9 $583,481 - $740,018	-13,989 Reduced 3.02%	449,094 $20.6 Million
Q1 2024 May 14, 2024	SELL	$32.52 - $52.33 $2.94 Million - $4.73 Million	-90,443 Reduced 16.34%	463,083 $24.1 Million
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $69,196 - $83,192	2,243 Added 0.41%	553,526 $19.7 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $8.04 Million - $9.95 Million	253,615 Added 85.2%	551,283 $18.5 Million
Q2 2023 Aug 14, 2023	SELL	$29.0 - $38.37 $96,773 - $128,040	-3,337 Reduced 1.11%	297,668 $11.2 Million
Q1 2023 May 17, 2023	BUY	$23.85 - $31.34 $122,779 - $161,338	5,148 Added 1.74%	301,005 $8.83 Million
Q4 2022 Feb 08, 2023	BUY	$17.65 - $27.37 $4.36 Million - $6.76 Million	247,088 Added 506.65%	295,857 $7.79 Million
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $55,984 - $80,536	2,475 Added 5.35%	48,769 $1.13 Million
Q2 2022 Aug 16, 2022	BUY	$22.88 - $39.45 $187,227 - $322,819	8,183 Added 21.47%	46,294 $1.17 Million
Q1 2022 May 13, 2022	BUY	$31.69 - $43.29 $380 - $519	12 Added 0.03%	38,111 $1.46 Million
Q4 2021 Feb 16, 2022	BUY	$35.2 - $52.6 $14,326 - $21,408	407 Added 1.08%	38,099 $1.5 Million
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $9,455 - $12,189	-204 Reduced 0.54%	37,692 $1.84 Million
Q2 2021 Aug 19, 2021	BUY	$47.2 - $67.81 $6,844 - $9,832	145 Added 0.38%	37,896 $1.99 Million
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $1.17 Million - $2.25 Million	37,751 New	37,751 $2.1 Million

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.4M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Vericel Corp Transaction History